- Guselkumab - první inhibitor IL-23 v léčbě psoriázy2019 | Third Faculty of Medicine
- Guselkumab - the first selective IL-23 inhibitor for the treatment of psoriatic arthritis2023 | First Faculty of Medicine
- Risankizumab in first-line treatment of psoriasis2022 | Faculty of Medicine in Pilsen
- Risankizumab in treatment of psoriatic arthritis2023 | First Faculty of Medicine
- Recommendations of the Czech Society of Rheumatology for the treatment of psoriatic arthritis2023 | First Faculty of Medicine
